• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.68 0.02(2.86%) Jan 28, 4:00PM EST
    Add to Portfolio
    Prev Close:0.70
    Open:0.71
    Bid:0.60 x 100
    Ask:1.90 x 3000
    1y Target Est:3.50
    Beta:1.56
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:0.68 - 0.73
    52wk Range:0.53 - 1.52
    Volume:274,721
    Avg Vol (3m):494,506
    Market Cap:42.65M
    P/E (ttm):N/A
    EPS (ttm):-0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 2.86%42.65M
    AGEN317.18M
    DNDNN/A
    STML192.96M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.17
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback